Cesura A - Search Results

1

The histamine H3 receptor as a therapeutic drug target for CNS disorders.

Gemkow MJ, Davenport AJ, Harich S, Ellenbroek BA, Cesura A, Hallett D. Gemkow MJ, et al. Among authors: cesura a. Drug Discov Today. 2009 May;14(9-10):509-15. doi: 10.1016/j.drudis.2009.02.011. Epub 2009 Mar 6. Drug Discov Today. 2009. PMID: 19429511 Review.

2

Fragment-based discovery of BACE1 inhibitors using functional assays.

Godemann R, Madden J, Krämer J, Smith M, Fritz U, Hesterkamp T, Barker J, Höppner S, Hallett D, Cesura A, Ebneth A, Kemp J. Godemann R, et al. Among authors: cesura a. Biochemistry. 2009 Nov 17;48(45):10743-51. doi: 10.1021/bi901061a. Biochemistry. 2009. PMID: 19799414

3

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.

Borroni E, Bohrmann B, Grueninger F, Prinssen E, Nave S, Loetscher H, Chinta SJ, Rajagopalan S, Rane A, Siddiqui A, Ellenbroek B, Messer J, Pähler A, Andersen JK, Wyler R, Cesura AM. Borroni E, et al. Among authors: cesura am. J Pharmacol Exp Ther. 2017 Sep;362(3):413-423. doi: 10.1124/jpet.117.241653. Epub 2017 Jun 22. J Pharmacol Exp Ther. 2017. PMID: 28642233

4

The structure of mammalian serine racemase: evidence for conformational changes upon inhibitor binding.

Smith MA, Mack V, Ebneth A, Moraes I, Felicetti B, Wood M, Schonfeld D, Mather O, Cesura A, Barker J. Smith MA, et al. Among authors: cesura a. J Biol Chem. 2010 Apr 23;285(17):12873-81. doi: 10.1074/jbc.M109.050062. Epub 2010 Jan 27. J Biol Chem. 2010. PMID: 20106978 Free PMC article.

5

Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.

Colzi A, D'Agostini F, Cesura AM, Borroni E, Da Prada M. Colzi A, et al. Among authors: cesura am. J Pharmacol Exp Ther. 1993 Apr;265(1):103-11. J Pharmacol Exp Ther. 1993. PMID: 8473998

6

Lazabemide for the treatment of Alzheimer's disease: rationale and therapeutic perspectives.

Cesura AM, Borroni E, Gottowik J, Kuhn C, Malherbe P, Martin J, Richards JG. Cesura AM, et al. Adv Neurol. 1999;80:521-8. Adv Neurol. 1999. PMID: 10410766 Review. No abstract available.

7

Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology.

Richards JG, Saura J, Luque JM, Cesura AM, Gottowik J, Malherbe P, Borroni E, Gray J. Richards JG, et al. Among authors: cesura am. J Neural Transm Suppl. 1998;52:173-87. doi: 10.1007/978-3-7091-6499-0_17. J Neural Transm Suppl. 1998. PMID: 9564618 Review.

8

A preclinical re-evaluation of the safety profile of tolcapone.

Borroni E, Cesura AM, Gatti S, Gasser R. Borroni E, et al. Among authors: cesura am. Funct Neurol. 2001;16(4 Suppl):125-34. Funct Neurol. 2001. PMID: 11996507 Review. No abstract available.

9

The new generation of monoamine oxidase inhibitors.

Cesura AM, Pletscher A. Cesura AM, et al. Prog Drug Res. 1992;38:171-297. doi: 10.1007/978-3-0348-7141-9_3. Prog Drug Res. 1992. PMID: 1609114 Review.

10

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography.

Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Löffler J, Richards JG. Saura J, et al. Among authors: cesura am. Neuroscience. 1994 Sep;62(1):15-30. doi: 10.1016/0306-4522(94)90311-5. Neuroscience. 1994. PMID: 7816197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page